IBDEI1L0 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25276,2)
 ;;=^5010019
 ;;^UTILITY(U,$J,358.3,25277,0)
 ;;=M05.772^^107^1217^148
 ;;^UTILITY(U,$J,358.3,25277,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25277,1,3,0)
 ;;=3^Rheumatoid Arthritis of Left Ankle
 ;;^UTILITY(U,$J,358.3,25277,1,4,0)
 ;;=4^M05.772
 ;;^UTILITY(U,$J,358.3,25277,2)
 ;;=^5010020
 ;;^UTILITY(U,$J,358.3,25278,0)
 ;;=M05.79^^107^1217^154
 ;;^UTILITY(U,$J,358.3,25278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25278,1,3,0)
 ;;=3^Rheumatoid Arthritis of Multiple Sites
 ;;^UTILITY(U,$J,358.3,25278,1,4,0)
 ;;=4^M05.79
 ;;^UTILITY(U,$J,358.3,25278,2)
 ;;=^5010022
 ;;^UTILITY(U,$J,358.3,25279,0)
 ;;=M06.00^^107^1217^161
 ;;^UTILITY(U,$J,358.3,25279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25279,1,3,0)
 ;;=3^Rheumatoid Arthritis w/o Rhematoid Factor,Unspec Site
 ;;^UTILITY(U,$J,358.3,25279,1,4,0)
 ;;=4^M06.00
 ;;^UTILITY(U,$J,358.3,25279,2)
 ;;=^5010047
 ;;^UTILITY(U,$J,358.3,25280,0)
 ;;=M06.30^^107^1217^164
 ;;^UTILITY(U,$J,358.3,25280,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25280,1,3,0)
 ;;=3^Rheumatoid Nodule,Unspec Site
 ;;^UTILITY(U,$J,358.3,25280,1,4,0)
 ;;=4^M06.30
 ;;^UTILITY(U,$J,358.3,25280,2)
 ;;=^5010096
 ;;^UTILITY(U,$J,358.3,25281,0)
 ;;=M06.4^^107^1217^51
 ;;^UTILITY(U,$J,358.3,25281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25281,1,3,0)
 ;;=3^Inflammatory Polyarthropathy
 ;;^UTILITY(U,$J,358.3,25281,1,4,0)
 ;;=4^M06.4
 ;;^UTILITY(U,$J,358.3,25281,2)
 ;;=^5010120
 ;;^UTILITY(U,$J,358.3,25282,0)
 ;;=M06.39^^107^1217^163
 ;;^UTILITY(U,$J,358.3,25282,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25282,1,3,0)
 ;;=3^Rheumatoid Nodule,Mult Sites
 ;;^UTILITY(U,$J,358.3,25282,1,4,0)
 ;;=4^M06.39
 ;;^UTILITY(U,$J,358.3,25282,2)
 ;;=^5010119
 ;;^UTILITY(U,$J,358.3,25283,0)
 ;;=M15.0^^107^1217^127
 ;;^UTILITY(U,$J,358.3,25283,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25283,1,3,0)
 ;;=3^Primary Generalized Osteoarthritis
 ;;^UTILITY(U,$J,358.3,25283,1,4,0)
 ;;=4^M15.0
 ;;^UTILITY(U,$J,358.3,25283,2)
 ;;=^5010762
 ;;^UTILITY(U,$J,358.3,25284,0)
 ;;=M06.9^^107^1217^162
 ;;^UTILITY(U,$J,358.3,25284,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25284,1,3,0)
 ;;=3^Rheumatoid Arthritis,Unspec
 ;;^UTILITY(U,$J,358.3,25284,1,4,0)
 ;;=4^M06.9
 ;;^UTILITY(U,$J,358.3,25284,2)
 ;;=^5010145
 ;;^UTILITY(U,$J,358.3,25285,0)
 ;;=M16.0^^107^1217^130
 ;;^UTILITY(U,$J,358.3,25285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25285,1,3,0)
 ;;=3^Primary Osteoarthritis of Hip,Bilateral
 ;;^UTILITY(U,$J,358.3,25285,1,4,0)
 ;;=4^M16.0
 ;;^UTILITY(U,$J,358.3,25285,2)
 ;;=^5010769
 ;;^UTILITY(U,$J,358.3,25286,0)
 ;;=M16.11^^107^1217^139
 ;;^UTILITY(U,$J,358.3,25286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25286,1,3,0)
 ;;=3^Primary Osteoarthritis of Right Hip
 ;;^UTILITY(U,$J,358.3,25286,1,4,0)
 ;;=4^M16.11
 ;;^UTILITY(U,$J,358.3,25286,2)
 ;;=^5010771
 ;;^UTILITY(U,$J,358.3,25287,0)
 ;;=M16.12^^107^1217^133
 ;;^UTILITY(U,$J,358.3,25287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25287,1,3,0)
 ;;=3^Primary Osteoarthritis of Left Hip
 ;;^UTILITY(U,$J,358.3,25287,1,4,0)
 ;;=4^M16.12
 ;;^UTILITY(U,$J,358.3,25287,2)
 ;;=^5010772
 ;;^UTILITY(U,$J,358.3,25288,0)
 ;;=M17.0^^107^1217^129
 ;;^UTILITY(U,$J,358.3,25288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25288,1,3,0)
 ;;=3^Primary Osteoarthritis of Bilateral Knees
 ;;^UTILITY(U,$J,358.3,25288,1,4,0)
 ;;=4^M17.0
 ;;^UTILITY(U,$J,358.3,25288,2)
 ;;=^5010784
